David Mitchell, PharmD, MBA, UC Davis, shares how collaboration between health systems and manufacturers is transforming patient access and outcomes for rare disease treatments.
In many primary markets, suitable data center sites with a clear path to permitting and access to utility power are ...
Discover why Oracle is a top buy, fueled by AI infrastructure growth and a $455B backlog. Click here to read my most recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback